UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amphastar Pharmaceuticals is implementing good security practices.
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.
This report shows a preliminary security rating for Amphastar Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Privilege escalation is the exploitation of a programming error, vulnerability, design flaw, ...
Data loss prevention (DLP) is a set of processes and technologies that ensure sensitive data is not ...
Compare Amphastar Pharmaceuticals's security performance with other companies